Related Experiment Videos
Wound endometriosis: risk factor evaluation and treatment
Peng-Hui Wang1, Chi-Mou Juang, Hsiang-Tai Chao
1Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC. phwang@vghtpe.gov.tw
Journal of the Chinese Medical Association : JCMA
|April 29, 2003
Summary
Obstetric surgery is a significant risk factor for developing wound endometriosis, a rare condition. Combination therapy including surgical excision and GnRH-agonist or Danazol may reduce recurrence.
Area of Science:
- Gynecology
- Surgical Pathology
Background:
- Wound endometriosis is a rare complication following surgical procedures.
- Identifying risk factors and effective management strategies is crucial.
Purpose of the Study:
- To identify risk factors associated with wound endometriosis.
- To present management experiences for this rare condition.
Main Methods:
- Retrospective study of 23 women with pathologically confirmed wound endometriosis.
- Analysis of surgical types (obstetric, gynecologic, laparoscopic) and preoperative CA-125 levels.
Main Results:
- Obstetric surgery showed a significantly higher occurrence rate (2.7/1000) and relative risk (7.71) compared to laparoscopic procedures.
- Abnormal preoperative CA-125 levels were associated with a shorter time to endometriosis occurrence.
- Combination therapy (surgical excision + GnRH-agonist/Danazol) reduced recurrence rates (11% vs. 42.9%).
Conclusions:
- Obstetric surgery is a potential risk factor for wound endometriosis.
- Aggressive endometriosis behavior may influence the timing of occurrence.
- Individualized therapy combining surgical excision with adjuvant treatments like GnRH-agonist or Danazol shows promise for reducing recurrence.